Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982755priorityCriticalpatent/ECSP982755A/en
Publication of ECSP982755ApublicationCriticalpatent/ECSP982755A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se reinvindica compuestos de la fórmula: (gráfico) y sus sales farmacéuticamente aceptables, en la que R1, R2, R3 y n se definen como en la memoria descriptiva, intermedios en la sintesis de tales compuestos, composiciones farmacéuticas que contienen tales compuestos y procedimientos para usar tales compuestos en el tratamiento de trastornos y psicológicos.Compounds of the formula: (graph) and their pharmaceutically acceptable salts are claimed, wherein R1, R2, R3 and n are defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods for using such compounds in the treatment of psychological and disorders.
COMPOUNDS DERIVED FROM FENACIL-2-HIDROXI-3-DIAMINOALCANS, INHIBITORS OF THE ENZYME BETASECRETASA, USEFUL TO PREPARE A MEDICINAL PRODUCT TO TREAT ALZHEIMER, DOWN SYNDROME, HEREDITAR CEREBRAL HERIDAL AND OEREDOS